Skip to main content
Intermediate Technical IVT

paraneoplastic syndrome

Pronunciation: /ˌpærəniːoʊˈplæstɪk/

Clinical manifestations caused by tumor-secreted substances rather than direct tumor effects.

Full Definition

Paraneoplastic syndromes are clinical manifestations that occur as a result of cancer but are not directly caused by the physical presence of tumor cells. These syndromes result from substances secreted by tumors, including hormones, cytokines, and other bioactive molecules that affect distant organs and systems. Common examples include hypercalcemia of malignancy, syndrome of inappropriate antidiuretic hormone secretion (SIADH), and various neurologic syndromes. Paraneoplastic syndromes may be the first sign of cancer, can significantly impact patient quality of life, and sometimes resolve after successful tumor treatment. Recognition of these syndromes is important for diagnosis, staging, and treatment planning.

Usage

Usage note: Specify the type of paraneoplastic syndrome and its relationship to the underlying malignancy.

In Context

  • "The patient presented with paraneoplastic syndrome manifesting as severe hypercalcemia." — Emergency department note
  • "Resolution of the paraneoplastic syndrome confirmed successful tumor treatment." — Follow-up assessment

Also known as

remote effects of cancer indirect tumor effects

Contrasted with

direct tumor effects mass effect

Don't confuse with

metastatic disease treatment toxicity

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON